Author

Jing Tian

Institutions: Emergent BioSolutions (United Kingdom), Emergent BioSolutions (United States)

Observed institutions: Capital Medical University, Emergent BioSolutions (United Kingdom), Emergent BioSolutions (United States), Beijing Children’s Hospital

ORCID: 0000-0002-9098-380X

Observed ORCID: 0000-0002-9098-380X

OpenAlex ID: A5015985107

Epidemiology of urticaria in China: a population-based study

2022 · Jiaqing Li, Dandan Mao, et al. · Chinese Medical Journal · 51

Brincidofovir in the Era of Mpox

2025 · James McCarty, David Cassie, et al. · Expert Review of Anti-infective Therapy · 11

Advances in the treatment of solid tumors in children and adolescents

2023 · Jing Tian, Jiayu Wang, et al. · Cancer Innovation · 11

A Healthy Participant Study to Evaluate the Bioequivalence of Form H and Form II Tablets of the Smallpox Antiviral Brincidofovir

2025 · David M Cassie, Vanja Komlenovic, et al. · ASEAN Journal of Psychiatry

A 6-Year-Old Boy With Cough, Mucositis, and Vesiculobullous Skin Lesions

2022 · Jing Tian, Teng Zhu, et al. · JAMA

Works count: 5

Citation count: 73

H-index: 3

I10-index: 3